Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
311.07
-3.90 (-1.24%)
Mar 13, 2025, 4:00 PM EST - Market closed
Molina Healthcare Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Molina Healthcare stock have an average target of 356.4, with a low estimate of 297 and a high estimate of 439. The average target predicts an increase of 14.57% from the current stock price of 311.07.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Molina Healthcare stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 4 | 4 | 3 | 3 | 3 | 5 |
Hold | 6 | 6 | 7 | 6 | 8 | 7 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 13 | 13 | 13 | 12 | 14 | 15 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wells Fargo | Wells Fargo | Hold → Buy Upgrades $295 → $372 | Hold → Buy | Upgrades | $295 → $372 | +19.59% | Mar 5, 2025 |
Mizuho | Mizuho | Buy Maintains $382 → $376 | Buy | Maintains | $382 → $376 | +20.87% | Mar 3, 2025 |
Truist Securities | Truist Securities | Strong Buy Maintains $370 → $340 | Strong Buy | Maintains | $370 → $340 | +9.30% | Feb 19, 2025 |
Barclays | Barclays | Hold Maintains $372 → $339 | Hold | Maintains | $372 → $339 | +8.98% | Feb 7, 2025 |
UBS | UBS | Hold Maintains $330 → $305 | Hold | Maintains | $330 → $305 | -1.95% | Feb 7, 2025 |
Financial Forecast
Revenue This Year
44.24B
Revenue Next Year
47.76B
from 44.24B
Increased by 7.96%
EPS This Year
24.83
from 20.42
Increased by 21.59%
EPS Next Year
28.69
from 24.83
Increased by 15.55%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 46.8B | 51.0B | 56.9B | |
Avg | 44.2B | 47.8B | 51.4B | |
Low | 40.9B | 44.0B | 47.9B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | - | 15.4% | 19.2% | |
Avg | - | 8.0% | 7.6% | |
Low | - | -0.6% | 0.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 28.56 | 32.55 | 37.38 | ||
Avg | 24.83 | 28.69 | 32.66 | ||
Low | 21.46 | 26.55 | 29.90 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 39.9% | 31.1% | 30.3% | ||
Avg | 21.6% | 15.5% | 13.8% | ||
Low | 5.1% | 6.9% | 4.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.